Detalhe da pesquisa
1.
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
BMC Cancer
; 24(1): 171, 2024 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38310262
2.
Analysis of left ventricle regional myocardial motion for cardiac radioablation: Left ventricular motion analysis.
J Appl Clin Med Phys
; 25(5): e14333, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38493500
3.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet
; 393(10185): 2051-2058, 2019 05 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30982687
4.
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
Oncologist
; 25(11): 981-992, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32860288
5.
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
BMC Cancer
; 20(1): 380, 2020 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32370765
6.
SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol.
BMC Cancer
; 19(1): 1011, 2019 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31660894
7.
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer
; 19(1): 816, 2019 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31426760
8.
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.
BMC Cancer
; 18(1): 954, 2018 Oct 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30286739
9.
Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research.
Healthc Manage Forum
; 31(1): 13-17, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29264976
10.
Prototype development of an electrical impedance based simultaneous respiratory and cardiac monitoring system for gated radiotherapy.
Biomed Eng Online
; 13: 144, 2014 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-25316509
11.
Left ventricle segment-specific motion assessment for cardiac-gated radiosurgery.
Biomed Phys Eng Express
; 10(2)2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38359447
12.
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1497-1506, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38220069
13.
Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
Clin Colorectal Cancer
; 22(1): 120-128, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36526537
14.
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.
Curr Oncol
; 30(4): 3817-3828, 2023 03 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37185402
15.
Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations.
Lung Cancer
; 179: 107166, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36944282
16.
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol
; 30(7): 6289-6315, 2023 06 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37504325
17.
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial.
Radiother Oncol
; 182: 109576, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36822355
18.
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(4): 617-626, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35667528
19.
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(5): 856-861, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35840110
20.
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.
Curr Oncol
; 29(5): 3160-3170, 2022 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35621647